Gold Rate

Vivimed Labs Ltd.

BSE: 532660 | NSE: VIVIMEDLAB |

Shares falling in the `Trade-to-Trade` or `T-segment` are traded in this series and no intraday is allowed. This means trades can only be settled by accepting or giving the delivery of shares.

Series: BE | ISIN: INE526G01021 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Vivimed Labs L Vivimed Labs Ltd. | BSE 7.38 -0.26 (-3.40%) | NSE 7.53 -0.10 (-1.31%) | Trade | Add

BSE Live

Apr 21, 12:52

7.38 -0.26 (-3.40%)

Volume

AVERAGE VOLUME

5-Day

27,428

10-Day

14,051

30-Day

18,612

14,522

Prev. Close

7.64
Open Price

7.56

Bid Price (Qty.)
7.38 (1575)
Offer Price (Qty.)
7.55 (500)

NSE Live

Apr 21, 12:49

7.53 -0.10 (-1.31%)

Volume

AVERAGE VOLUME

5-Day

149,181

10-Day

102,281

30-Day

150,477

73,919

Prev. Close

7.63
Open Price

7.63

Bid Price (Qty.)
7.47 (400)
Offer Price (Qty.)
7.53 (340)

Financials

Print/Copy to Excel : Go

Balance Sheet of Vivimed Labs (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	16.58	16.58	16.58	16.58	16.58
Total Share Capital	16.58	16.58	16.58	16.58	16.58
Reserves and Surplus	-89.75	-60.04	-15.16	309.70	376.99
Total Reserves and Surplus	-51.75	-22.04	22.84	347.70	414.99
Total Shareholders Funds	-35.17	-5.46	39.42	364.29	431.58
Minority Interest	0.00	0.00	0.00	0.00	0.00
NON-CURRENT LIABILITIES
Long Term Borrowings	63.62	63.57	62.32	60.99	57.79
Deferred Tax Liabilities [Net]	8.62	9.03	9.52	11.68	8.60
Other Long Term Liabilities	470.75	468.55	448.41	447.30	443.58
Long Term Provisions	4.82	4.90	4.38	8.36	6.72
Total Non-Current Liabilities	547.81	546.05	524.62	528.34	516.68
CURRENT LIABILITIES
Short Term Borrowings	312.71	313.36	316.25	297.89	195.25
Trade Payables	39.43	44.07	69.41	41.89	34.25
Other Current Liabilities	54.58	51.50	37.39	33.05	110.68
Short Term Provisions	1.48	1.39	1.25	0.56	0.90
Total Current Liabilities	408.20	410.33	424.30	373.39	341.08
Total Capital And Liabilities	920.83	950.91	988.34	1,266.02	1,289.33
ASSETS
NON-CURRENT ASSETS
Tangible Assets	254.40	262.86	278.18	362.57	348.13
Intangible Assets	136.36	138.15	140.73	140.42	136.63
Capital Work-In-Progress	17.11	20.65	20.67	40.03	60.12
Fixed Assets	407.87	421.66	439.57	543.01	544.88
Non-Current Investments	168.50	168.50	198.82	198.82	198.82
Deferred Tax Assets [Net]	0.00	0.44	0.00	0.00	0.00
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.82	0.76	0.00	0.00
Total Non-Current Assets	593.28	608.33	656.06	758.75	760.62
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	58.76	64.06	79.76	240.77	255.68
Trade Receivables	74.11	82.82	76.81	87.36	107.50
Cash And Cash Equivalents	0.71	2.03	3.76	7.18	6.43
Short Term Loans And Advances	46.93	41.42	39.80	42.95	95.14
OtherCurrentAssets	147.06	152.26	132.15	129.01	63.96
Total Current Assets	327.55	342.58	332.29	507.27	528.71
Total Assets	920.83	950.91	988.34	1,266.02	1,289.33
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	182.90	115.79	123.42	215.57	220.66
BONUS DETAILS
Bonus Equity Share Capital	0.00	0.00	0.00	0.00	0.00
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	168.50	168.50	198.82	198.82	198.82
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00